Blog

VUMC begins study of second COVID-19 vaccine

Vanderbilt University Medical Center has begun recruiting up to 250 participants for a phase 3 clinical trial testing an investigational COVID-19 vaccine candidate developed by the Janssen Pharmaceutical Companies of Johnson & Johnson.


Jerri Rook is awarded the Alzheimer’s Drug Discovery Foundation’s prestigious Melvin R. Goodes prize

Vanderbilt University Assistant Professor of Pharmacology Jerri Rook has been recognized with the 2020 Melvin R. Goodes Prize for Excellence in Alzheimer’s Drug Discovery. Presented by the Alzheimer’s Drug Discovery Foundation, the prize recognizes leading researchers who are developing treatments for Alzheimer’s disease and related dementias.